{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:12:02Z","timestamp":1778519522687,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,31]],"date-time":"2025-05-31T00:00:00Z","timestamp":1748649600000},"content-version":"am","delay-in-days":272,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 5T32EY027816-05"],"award-info":[{"award-number":["T32 5T32EY027816-05"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1EY030151"],"award-info":[{"award-number":["RO1EY030151"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1EY031952"],"award-info":[{"award-number":["RO1EY031952"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30EY026877"],"award-info":[{"award-number":["P30EY026877"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RO1EY031360"],"award-info":[{"award-number":["RO1EY031360"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006312","name":"BrightFocus Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005492","name":"Stanford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005492","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic & Medicinal Chemistry Letters"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bmcl.2024.129814","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T19:49:34Z","timestamp":1716925774000},"page":"129814","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Identification of highly potent and selective HTRA1 inhibitors"],"prefix":"10.1016","volume":"109","author":[{"given":"David G.","family":"Dennis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young","family":"Joo Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dylan E.","family":"Parsons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vinit B.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0313-5723","authenticated-orcid":false,"given":"Mark","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmcl.2024.129814_b0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41572-021-00265-2","article-title":"Age-related macular degeneration","volume":"7","author":"Fleckenstein","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.bmcl.2024.129814_b0010","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.joca.2011.11.008","article-title":"Osteoarthritis-like Changes in the Heterozygous Sedc Mouse Associated with the HtrA1-Ddr2-Mmp-13 Degradative Pathway: A New Model of Osteoarthritis","volume":"20","author":"Holt","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/j.bmcl.2024.129814_b0015","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1111\/cns.13730","article-title":"The Role of Vascular Dementia Associated Genes in Patients with Alzheimer\u2019s Disease: A Large Case-Control Study in the Chinese Population","volume":"27","author":"Xiao","year":"2021","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.bmcl.2024.129814_b0020","first-page":"2650","article-title":"HtrA1 in Human Urothelial Bladder Cancer: A Secreted Protein and a Potential Novel Biomarker","volume":"133","author":"Lorenzi","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.bmcl.2024.129814_b0025","doi-asserted-by":"crossref","first-page":"21335","DOI":"10.1074\/jbc.M112.341032","article-title":"Detrimental Role for Human High Temperature Requirement Serine Protease A1 (HTRA1) in the Pathogenesis of Intervertebral Disc (IVD) Degeneration","volume":"287","author":"Tiaden","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2024.129814_b0030","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.preghy.2019.08.005","article-title":"Association between First Trimester Plasma Htra1 Level and Subsequent Preeclampsia: A Possible Early Marker?","volume":"18","author":"Gesuita","year":"2019","journal-title":"Pregnancy Hypertens."},{"key":"10.1016\/j.bmcl.2024.129814_b0035","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1021\/acs.jproteome.7b00188","article-title":"Proteomic Analysis of Amyloid Corneal Aggregates from TGFBI-H626R Lattice Corneal Dystrophy Patient Implicates Serine-Protease in Mutation-Specific Pathogenesis of TGFBIp","volume":"16","author":"Venkatraman","year":"2017","journal-title":"J Proteome Res"},{"key":"10.1016\/j.bmcl.2024.129814_b0040","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1016\/j.sjbs.2021.11.056","article-title":"Interplay between and Classical Signalling Pathways in Organogenesis and Diseases","volume":"29","author":"Oka","year":"2022","journal-title":"Saudi Journal of Biological Sciences"},{"key":"10.1016\/j.bmcl.2024.129814_b0045","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1038\/nrm3065","article-title":"HTRA Proteases: Regulated Proteolysis in Protein Quality Control","volume":"12","author":"Clausen","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.bmcl.2024.129814_b0050","doi-asserted-by":"crossref","first-page":"6124","DOI":"10.1074\/jbc.M500361200","article-title":"The Role of Human HtrA1 in Arthritic Disease","volume":"281","author":"Grau","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bmcl.2024.129814_b0055","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1172\/JCI25843","article-title":"Drusen Deposits Associated with Aging and Age-Related Macular Degeneration Contain Nonfibrillar Amyloid Oligomers","volume":"116","author":"Luibl","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.bmcl.2024.129814_b0060","doi-asserted-by":"crossref","unstructured":"Jones A, Kumar S, Zhang N, Tong Z, Yang JH, Watt C, Anderson J, Amrita, Fillerup H, McCloskey M, Luo L, Yang Z, Ambati B, Marc R, Oka C, Zhang K, Fu Y. Increased Expression of Multifunctional Serine Protease, HTRA1, in Retinal Pigment Epithelium Induces Polypoidal Choroidal Vasculopathy in Mice. Proc. Natl. Acad. Sci. 2011;108:14578\u201314583. https:\/\/doi.org\/10.1073\/pnas.1102853108.","DOI":"10.1073\/pnas.1102853108"},{"key":"10.1016\/j.bmcl.2024.129814_b0065","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1126\/science.1133811","article-title":"A variant of the HTRA1 gene increases susceptibility to age-related macular degeneration","volume":"314","author":"Yang","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bmcl.2024.129814_b0070","doi-asserted-by":"crossref","first-page":"3445","DOI":"10.1093\/hmg\/ddu053","article-title":"Validation of genome-wide association study (GWAS)-identified disease risk alleles with patient-specific stem cell lines","volume":"23","author":"Yang","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.bmcl.2024.129814_b0075","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng1873","article-title":"Common Variation in Three Genes, Including a Noncoding Variant in CFH, Strongly Influences Risk of Age-Related Macular Degeneration","volume":"38","author":"Maller","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/j.bmcl.2024.129814_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep28639","article-title":"HTRA1 Promoter Variant Differentiates Polypoidal Choroidal Vasculopathy from Exudative Age-Related Macular Degeneration","volume":"6","author":"Ng","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.bmcl.2024.129814_b0085","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/eye.2015.48","article-title":"Defining Response to Anti-VEGF Therapies in Neovascular AMD","volume":"29","author":"Amoaku","year":"2015","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.bmcl.2024.129814_b0090","doi-asserted-by":"crossref","first-page":"9952","DOI":"10.1073\/pnas.1917608117","article-title":"Development of a Therapeutic Anti-HtrA1 Antibody and the Identification of DKK3 as a Pharmacodynamic Biomarker in Geographic Atrophy","volume":"117","author":"Tom","year":"2020","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmcl.2024.129814_b0095","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajo.2021.06.017","article-title":"Phase 1 Study of the Anti-HtrA1 Antibody-Binding Fragment FHTR2163 in Geographic Atrophy Secondary to Age-Related Macular Degeneration","volume":"232","author":"Khanani","year":"2021","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.bmcl.2024.129814_b0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ophtha.2019.07.011","article-title":"Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial","volume":"127","author":"Liao","year":"2020","journal-title":"Ophthalmology"},{"key":"10.1016\/j.bmcl.2024.129814_b0105","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1038\/s41433-023-02497-w","article-title":"Avacincaptad Pegol for Geographic Atrophy Secondary to Age-Related Macular Degeneration: 18-Month Findings from the GATHER1 Trial","volume":"37","author":"Patel","year":"2023","journal-title":"Eye"},{"key":"10.1016\/j.bmcl.2024.129814_b0110","unstructured":"Baccei JM, Oballa RM, Powell DA, Roppe JR, Sheng T, Stearn B. Boronic Acid Derivatives and Uses Thereof. WO 2016\/100555 A1, 23 June 2016."},{"key":"10.1016\/j.bmcl.2024.129814_b0115","unstructured":"Hornsperger B, Maerki HP, Mohr P, Reutlinger M, Rudolph M. New Difluoroketamide Derivatives as HTRA1 Inhibitors. WO 2018\/036942 A1, 01 March, 2018."},{"key":"10.1016\/j.bmcl.2024.129814_b0120","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1038\/nsmb.2013","article-title":"Substrate-induced remodeling of the active site regulates human HTRA1 activity","volume":"18","author":"Truebestein","year":"2011","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.bmcl.2024.129814_b0125","unstructured":"Unpublished results."},{"key":"10.1016\/j.bmcl.2024.129814_b0130","doi-asserted-by":"crossref","first-page":"e202200020","DOI":"10.1002\/cmdc.202200020","article-title":"Cyclobutanes in small-molecule drug candidates","volume":"17","author":"van der Kolk","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmcl.2024.129814_b0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1021\/acsmedchemlett.3c00037","article-title":"Beyond 20 in the 21st Century: Prospects and Challenges of Non-Canonical Amino Acids in Peptide Drug Discovery","volume":"14","author":"Hickey","year":"2023","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmcl.2024.129814_b0140","doi-asserted-by":"crossref","first-page":"10009","DOI":"10.1021\/jo4013942","article-title":"Boronic esters in asymmetric synthesis","volume":"78","author":"Matteson","year":"2013","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmcl.2024.129814_b0145","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1021\/jo500300t","article-title":"Asymmetric Synthesis of Protected \u03b1-Amino Boronic Acid Derivatives with an Air- and Moisture-Stable Cu(II) Catalyst","volume":"79","author":"Buesking","year":"2014","journal-title":"J Org Chem"}],"container-title":["Bioorganic & Medicinal Chemistry Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960894X24002166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T16:40:18Z","timestamp":1778517618000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960894X24002166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":29,"alternative-id":["S0960894X24002166"],"URL":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129814","relation":{},"ISSN":["0960-894X"],"issn-type":[{"value":"0960-894X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of highly potent and selective HTRA1 inhibitors","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmcl.2024.129814","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"129814"}}